Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Checking a Spanish version of two arm movement tests after stroke

Tests Spanish versions of two arm function scales in adults with chronic stroke.

Plain-language title generated from the registry record
Registry title: Psychometric Study of the Spanish Version of Two Upper Limb Assessment Scales in Chronic Stroke

Key facts

Where
Valencia, SpainSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT05872191, who can take part

Where in Spain

  • University of ValenciaValencia, SpainNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Valencia
Trial code
NCT05872191
Record updated
15 October 2026
Original description
The purpose of this cross-sectional study is to translate and cross-culturally adapt to Spanish the Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) and the Stroke Upper Limb Capacity Scale (SULCS) and to assess their psychometric properties in Spanish people with chronic stroke.Read full original descriptionShow less

Spanish-language Translation, Cross-cultural Adaption and Evaluation of the Psychometric Properties of Two Upper Limb Assessment Scales in People With Sequelae of Stroke in Chronic Phase

The purpose of this cross-sectional study is to translate and cross-culturally adapt to Spanish the Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) and the Stroke Upper Limb Capacity Scale (SULCS) and to assess their psychometric properties in Spanish people with chronic stroke.

Inclusion: Spanish-native speakers aged between 18 and 80 years with:; Functional impairment of the upper extremity due to hemiparesis secondary to a stroke of ≥6 months of evolution; Clinical stability; Sufficient cognitive capacity to give consent to participate in the study and to understand and perform the assessment tests.

Exclusion: Bilateral motor impairment; Neurological impairment other than stroke (both central and peripheral nervous systems), musculoskeletal impairment (amputation, fracture, etc.) or disabling pain (Visual Analogue Scale score > 5) that may affect the performance of the tests.

ClinicalTrials.gov NCT05872191